MVIS vs PATH
Microvision Inc (MVIS) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Microvision Inc (MVIS) is a scientific & technical instruments company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported MVIS revenue for 2024-12-31 was $4.7M. Net income was -$96.9M. Revenue was down 35.3% from 2023-12-31 to 2024-12-31. MVIS currently screens at market cap $200.4M.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
MVIS currently screens at market cap $200.4M. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the MVIS and PATH stock pages for the full models.
Not investment advice.